Given the predominance of tyrosine kinases in tumorigenesis, it might be anticipated that PTP1B inhibition favors cancer growth, since reduced PTP1B expression was found in hepatocellular carcinomas [85]. The gene discussed is PTPN1; the disease is hepatocellular carcinoma.